Stockscreener 앱 받기
1.63
1.24%
0.02
시간 외 거래:
1.63
Inhibikase Therapeutics Inc 주식(IKT)의 최신 뉴스
Has Inhibikase Therapeutics Inc. formed a bullish divergenceJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
Why Inhibikase Therapeutics Inc. stock is a must watch in 2025Quarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
Why Inhibikase Therapeutics Inc. is moving today2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Combining price and volume data for Inhibikase Therapeutics Inc.Earnings Miss & Low Drawdown Trading Techniques - newser.com
Custom watchlist performance reports with Inhibikase Therapeutics Inc.Day Trade & Real-Time Price Movement Reports - newser.com
How to build a custom watchlist for Inhibikase Therapeutics Inc.Swing Trade & Stock Market Timing Techniques - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock could be top winnerWeekly Market Summary & Real-Time Market Sentiment Reports - newser.com
Pattern recognition hints at Inhibikase Therapeutics Inc. upsideAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-12 03:48:12 - newser.com
Using data tools to time your Inhibikase Therapeutics Inc. exitGap Down & Verified Stock Trade Ideas - newser.com
Can trapped investors hope for a rebound in Inhibikase Therapeutics Inc.Sell Signal & Accurate Technical Buy Alerts - newser.com
Will Inhibikase Therapeutics Inc. stock go up soon2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Evaluating Inhibikase Therapeutics Inc. with trendline analysis2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com
How geopolitical risks impact Inhibikase Therapeutics Inc. (IQT0) stock2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock is a strong analyst pick2025 Short Interest & Daily Profit Focused Screening - newser.com
Is this a good reentry point in Inhibikase Therapeutics Inc.Trade Volume Summary & Free Growth Oriented Trading Recommendations - newser.com
Inhibikase Therapeutics (NASDAQ:IKT) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Inhibikase Therapeutics Inc Stock Analysis and ForecastHigh Dividend Yield Stocks & Breakthrough Profit Margins - earlytimes.in
What drives Inhibikase Therapeutics Inc IQT0 stock priceVolume Analysis Techniques & Free Explosive Trading Growth - earlytimes.in
Inhibikase Therapeutics Inc. stock outlook for YEARQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Market reaction to Inhibikase Therapeutics Inc.’s recent news2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
What MACD and RSI say about Inhibikase Therapeutics Inc.2025 Retail Activity & Safe Entry Point Alerts - newser.com
Leading vs lagging indicators on Inhibikase Therapeutics Inc. performance2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Inhibikase Therapeutics (NYSE:IKT) vs. LadRx (OTCMKTS:CYTR) Critical Contrast - Defense World
Has Inhibikase Therapeutics Inc. found a price floorPortfolio Return Summary & Short-Term Trading Alerts - newser.com
Using flow based indicators on Inhibikase Therapeutics Inc.CEO Change & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-03 06:03:22 - newser.com
Heatmap analysis for Inhibikase Therapeutics Inc. and competitorsMarket Trend Review & Step-by-Step Trade Execution Guides - newser.com
How to monitor Inhibikase Therapeutics Inc. with trend dashboardsPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
How to interpret RSI for Inhibikase Therapeutics Inc. stockInflation Watch & Low Risk High Win Rate Stock Picks - newser.com
1.11%
자본화:
|
볼륨(24시간):